x
Filter:
Filters applied
- HFSA Guidelines, Position Statements, and Consensus Statements
- Lindenfeld, JoannRemove Lindenfeld, Joann filter
- Seidman, Christine ERemove Seidman, Christine E filter
HFSA Guidelines, Position Statements, and Consensus Statements
1 Results
- Guideline
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Journal of Cardiac FailureVol. 15Issue 2p83–97Published in issue: March, 2009- Ray E. Hershberger
- Joann Lindenfeld
- Luisa Mestroni
- Christine E. Seidman
- Matthew R.G. Taylor
- Jeffrey A. Towbin
Cited in Scopus: 378Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.
